Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.

Nearly every $100,000 drug approved in the last three years was for a rare disease

Nearly every $100,000 drug approved in the last three years was for a rare disease

This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.

Study: One-third of new drugs report safety issues

Study: One-third of new drugs report safety issues

Drugs approved through the accelerated approval pathway, as well as psychiatric drugs, were more likely to have a safety issue following FDA approval.

Day 2 at Health Datapalooza

Day 2 at Health Datapalooza

The market for health data and technology is growing, but the industry must also address concerns about privacy, standards, and diversity.

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

Pharma R&D partnerships are on the rise: report

Pharma R&D partnerships are on the rise: report

This is likely due, in part, to the increasingly complex nature of new specialty drugs.

Off-label legal settlements do little to change prescribing patterns

Off-label legal settlements do little to change prescribing patterns

An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.

Large teaching hospitals more prone to breaches

Large teaching hospitals more prone to breaches

These facilities may be more prone to attack because there are more people at them with access to private patient data, whether to conduct medical research or educate new healthcare professionals.

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Organizations are focusing on better ways to verify HCPs' digital identities.

Patients are increasingly asking docs about drugs in DTC ads: poll

Patients are increasingly asking docs about drugs in DTC ads: poll

Docs said patients asked about drugs from DTC ads six times in a typical week, compared to just twice a week five years ago.

6 personalization practices from Walgreens' Balance Rewards program

6 personalization practices from Walgreens' Balance Rewards program

How the retail pharmacy chain uses customer data to make its marketing messages relevant.

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

Day 3 at JP Morgan: The move toward big data requires drugmakers to ask questions

There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.

Big data expert Hilary Mason on 3 ways to create a data-driven culture

Big data expert Hilary Mason on 3 ways to create a data-driven culture

The first step is to seek leadership support, she says.

Pharma adopts data-science culture in move toward AI

Pharma adopts data-science culture in move toward AI

Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.